Factors associated with weight changes in successful quitters participating in a smoking cessation program

Institute of Hygiene and Epidemiology, 1st Faculty of Medicine and the General University Hospital, Charles University, Prague, Czech Republic. Electronic address: .
Addictive behaviors (Impact Factor: 2.76). 10/2013; 39(1). DOI: 10.1016/j.addbeh.2013.10.010
Source: PubMed


To identify possible predictors of post-cessation weight gain in smoking abstainers.
A sample of 607 successful abstainers seen at the Centre for Tobacco-Dependent in Prague, Czech Republic, between 2005 and 2010, was included in this analysis. This sample was followed up for 1year and included 47.9% women (N=291) with the mean age of 48years (18-85).
Post-cessation weight gain occurred in 88.6% of the 607 abstainers. The mean weight gain after one year post-quit was 5.1kg (95% confidence interval 4.7-5.5kg). Baseline characteristics associated with increased weight gain included a higher baseline smoking rate (p<0.001), more severe cigarette dependence (p=0.003), less physical activity (p=0.008), and a report of increased appetite on the baseline assessment of withdrawal symptoms (p<0.001).
Smokers who are more dependent and have minimal physical activity are at increased risk for post-cessation weight gain. For these smokers, incorporating interventions targeting the weight issue into tobacco dependence treatment is recommended. Further research should be done to identify reasons for this important quitting complication.

Download full-text


Available from: Ivana Croghan,
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aim To assess tobacco use and some characteristics of tobacco users (including electronic cigarette users) relevant to cardiovascular disease in a representative population sample of the city of Brno. Methods A cross-sectional survey of cardiovascular risk factors was conducted using the methodology of the Czech post-MONICA Study, in the city of Brno, Czech Republic in 2013. This preliminary report of the first 965 randomly selected volunteers (including 512 women) aged 25–64, focuses on tobacco use, its prevalence in different subgroups as well as on the attitudes towards smoke-free policies. Results This preliminary analysis involves 965 individuals with a mean age of 47.3 ± 11.40 years. The prevalence of smoking was 26.7%, with daily tobacco use 23.3%, less than once daily 3.4%; 19.9% of the sample are ex-smokers. A total of 34.0% of the survey population reported exposure to passive smoking. Electronic cigarette use was observed in 3.5% of respondents, more common in men (5.1%) than in women (2.1%; p = 0.020). Concomitant use of electronic cigarettes and smoking was observed in 2.07% of the population. Conclusion The prevalence of tobacco use in the productive-age population of Brno City district is 26.70%, still a high figure.
    Cor et vasa 04/2014; 56(2). DOI:10.1016/j.crvasa.2014.02.005
  • [Show abstract] [Hide abstract]
    ABSTRACT: Smoking is the most important cardiovascular (CV) risk factor. Stopping smoking halves the CV risk. Every clinician should provide a brief intervention with smokers. Intensive treatment should be available to those who need it. There are 37 Centers for Tobacco Dependence in the Czech Republic, which offer treatment including a psychobehavioral intervention and pharmacotherapy (varenicline, nicotine, bupropion). Czech physicians, pharmacists and nurses are regularly educated about smoking cessation. We describe the results of intensive treatment offered by our centers. Treatment includes screening (1 h), an intervention (2 h), and follow-up visits during the next 12 months. Among 3532 patients, 34.3 % had CO-validated abstinence at 12-months (including 489 patients who attended the screening visit + only the 12-month follow up visit). Among patients who underwent the intervention, the abstinence rate was 38.2 %. The majority of patients who underwent the intervention (N=2470) used some form of pharmacotherapy. After one year, the abstinence rate was 43.4 %, compared to 15.9 % (N=573) without pharmacotherapy. Only 28 % of patients came on the recommendation of a physician. Despite the decrease in CV risk following smoking cessation and the effectiveness of treatment, centers are underutilized.
    Physiological research / Academia Scientiarum Bohemoslovaca 11/2014; 63 Suppl 3:S361-8. · 1.29 Impact Factor